Table 1 Comparison of various factors among three groups of IHCC patients classified by SSTR2 and Bcl2 expression
Factors | p-Group P (n = 14) | p-Group H (n = 21) | p-Group U (n = 17) |
|---|---|---|---|
Gender (M/F) | 9/5 | 13/8 | 5/12 |
Age (years old) | 68.7 ± 2.3 | 71.0 ± 1.9 | 69.6 ± 2.1 |
Hepatic virus infection (−/+) | 9/5 | 15/6 | 11/6 |
Curability (A, B/C) | 14/0 | 15/6 | 14/3 |
T (1, 2/3, 4) | 9/5a | 3/18a | 6/11 |
N (0/1–3) | 13/1 | 13/8 | 10/7 |
cStage (I, II/III, IV) | 9/5a,b | 2/19a | 4/13b |
Tumor type (MF/MF + PI) | 11/3a,b | 4/17a | 5/12b |
Tumor location (grossly peripheral/perihilar) | 14/0a | 16/5a,c | 17/0c |
Differentiation (Cholangiolo/tub1/others) | 5/3/6 | 0/9/12 | 1/2/14 |
Tumor thrombus in the portal vein (−/+) | 11/3 | 15/6 | 7/10 |
Tumor thrombus in the hepatic vein (−/+) | 12/2 | 18/3 | 15/2 |
Intrahepatic metastasis (−/+) | 12/2 | 17/4 | 12/5 |
Tumor thrombus in the bile duct (−/+) | 10/4 | 7/14 | 7/10 |
CEA†(ng/dL) (< 5/> 5) | 11/3 | 13/8 | 11/6 |
CA19-9‡ (U/mL) (< 100/> 100) | 10/4 | 7/14 | 7/9 |